D-0083-2023 Class II Terminated
FDA drug recall D-0083-2023 was initiated by Atlantic Management Resources Ltd. on Dec 12, 2022 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Sep 20, 2023). Affected quantity: 72 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 21, 2022
- Initiation Date
- Dec 12, 2022
- Termination Date
- Sep 20, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72 bottles
Product Description
ProSirona, A Homeopathic Formula, Calendula Oil packaged in 1/8 Fl. oz. (3.5 g) bottles, Dist. by: Endometriosis Assoc. Inc. (International), Mfg. by Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233-712-01.
Reason for Recall
cGMP Deviations
Distribution Pattern
Nationwide and Australia
Code Information
Lot Code B-02
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0083-2023
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026